Immunohistochemical distribution of tubulin beta II in human normal and neoplastic tissues. 2005

Eriko Oda, and Yasuhiro Nakamura, and Munehiko Yamamoto, and Masamichi Kojiro
Department of Chemistry, Kurume University School of Medicine, Kurume 830-0011, Japan. kumamaru@med.kurume-u.ac.jp

Tubulin is the major constituent protein of microtubules. In mammals, there are seven beta-tubulins and six alpha-tubulins. Each beta-tubulin isotype has a unique tissue distribution. The purpose of this study was to describe the distribution of tubulin beta II in normal and neoplastic human tissues with immunohistochemical techniques. We obtained normal tissues from 33 cases (8 fetuses, 17 neonates, 3 children and 5 adults) and 121 samples of neoplastic tissue from surgical specimens or at autopsy. Immunohistochemical staining for tubulin beta II was performed using a monoclonal antibody, KNY379 developed in our laboratory. Tubulin beta II was detected in various normal tissues, particularly in fetal and neonatal tissues, such as the nervous system, pulmonary alveoli, bronchioles and bronchi, colon, pancreatic ducts and acini, renal convoluted tubuli, skin epidermis, body cavity mesothelial cells, smooth muscle and thymus. In the adult, broad expression was also observed; however, the immunoreactivity was weaker and the extent of its distribution decreased with age. In neoplastic tissues, tubulin beta II immunoreactivity was detected in various nervous system neoplasms and other neoplasms such as pancreatic solid cystic carcinoma, pleomorphic adenoma, Warthin's tumor, nephroblastoma, basal cell carcinoma and malignant mesothelioma. We conclude that our monoclonal antibody, KNY379, may be useful as a marker of nervous system neoplasm, pancreatic solid cystic carcinoma, pleomorphic adenoma, Warthin's tumor, nephroblastoma, basal cell carcinoma and malignant mesothelioma.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007223 Infant A child between 1 and 23 months of age. Infants
D008654 Mesothelioma A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed) Mesotheliomas
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Eriko Oda, and Yasuhiro Nakamura, and Munehiko Yamamoto, and Masamichi Kojiro
March 1998, Histochemistry and cell biology,
Eriko Oda, and Yasuhiro Nakamura, and Munehiko Yamamoto, and Masamichi Kojiro
April 2017, Asian Pacific journal of cancer prevention : APJCP,
Eriko Oda, and Yasuhiro Nakamura, and Munehiko Yamamoto, and Masamichi Kojiro
January 2003, Breast cancer research : BCR,
Eriko Oda, and Yasuhiro Nakamura, and Munehiko Yamamoto, and Masamichi Kojiro
April 1992, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Eriko Oda, and Yasuhiro Nakamura, and Munehiko Yamamoto, and Masamichi Kojiro
November 2005, The Journal of clinical endocrinology and metabolism,
Eriko Oda, and Yasuhiro Nakamura, and Munehiko Yamamoto, and Masamichi Kojiro
December 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
Eriko Oda, and Yasuhiro Nakamura, and Munehiko Yamamoto, and Masamichi Kojiro
July 2002, Cell motility and the cytoskeleton,
Eriko Oda, and Yasuhiro Nakamura, and Munehiko Yamamoto, and Masamichi Kojiro
June 1991, Cancer,
Eriko Oda, and Yasuhiro Nakamura, and Munehiko Yamamoto, and Masamichi Kojiro
November 2021, International journal of molecular sciences,
Eriko Oda, and Yasuhiro Nakamura, and Munehiko Yamamoto, and Masamichi Kojiro
May 1993, Pathology, research and practice,
Copied contents to your clipboard!